Hematology Research Unit Helsinki (HRUH) is a translational research group, which aims to understand the pathobiology of malignant blood diseases (such as leukemia) and related autoimmune disorders, and find novel therapy targets and modes of action. We combine basic cancer research with clinical drug studies and our long-term goal is to develop curative treatment strategies for patients.